Geneuity CRS and Molecular Pathology Laboratory Network Inc. Vice President Genomic Solutions Jamie Platt Ph.D., will be presenting at San Diego illumina Medical Genomics Summit June 8th 2015. Dr. Platt will present “LDTs to NGS IVD Systems, a Customers Perspective” and discuss verification of the first FDA IVD use cleared MiSeqDx Next Generation Sequencing system. Dr. Platt will also highlight differences between Laboratory Developed Tests (LDT) and IVD assays in a CLIA environment and share experiences with the illumina IVD assay Cystic Fibrosis 139-Variant Assay (IVD).
MPLN Acquires the First FDA Approved High Throughput DNA Sequencing Analyzer
Illumina-MiSeqDx
Maryville, Tennessee based Molecular Pathology Laboratory Network, Inc. (MPLN) acquires the Illumina MiSeqDx™ next generation sequencing system to expand its portfolio of molecular testing and clinical research services to support growing demand in personalized medicine. Continue Reading…